Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in SARS-CoV-2 positive candidates is usually delayed until the clinical resolution of the infection’s symptoms and a negative nasopharyngeal molecular test. However, prolonged SARS-CoV-2 positivity has been frequently observed in haemato...

Descripción completa

Detalles Bibliográficos
Autores principales: Oltolini, Chiara, Acerbis, Andrea, Orofino, Giorgio, Racca, Sara, Noviello, Maddalena, Dispinseri, Stefania, Clementi, Nicola, Piemontese, Simona, Xue, Elisabetta, Giglio, Fabio, Lupo Stanghellini, Maria Teresa, Diral, Elisa, Bruno, Alessandro, Tassi, Elena, Beretta, Valeria, Marzinotto, Ilaria, Scarlatti, Gabriella, Lampasona, Vito, Ardemagni, Anna, Sampaolo, Michela, Bonini, Chiara, Corti, Consuelo, Peccatori, Jacopo, Castagna, Antonella, Ciceri, Fabio, Greco, Raffaella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242072/
https://www.ncbi.nlm.nih.gov/pubmed/37287986
http://dx.doi.org/10.3389/fimmu.2023.1184956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242072/
https://www.ncbi.nlm.nih.gov/pubmed/37287986
http://dx.doi.org/10.3389/fimmu.2023.1184956

Ejemplares similares